BDNF-GSK-3β-β-Catenin Pathway in the mPFC Is Involved in Antidepressant-Like Effects of Morinda officinalis Oligosaccharides in Rats
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Background: Morinda officinalis oligosaccharides have been reported to exert neuroprotective and antidepressant-like effects in the forced swim test in mice. However, the mechanisms that underlie the antidepressant-like effects of Morinda officinalis oligosaccharides are unclear. Methods: Chronic unpredictable stress and forced swim test were used to explore the antidepressant-like effects of Morinda officinalis oligosaccharides and resilience to stress in rats. The phosphoinositide-3 kinase inhibitor LY294002 was microinjected in the medial prefrontal cortex to explore the role of glycogen synthase kinase-3β in the antidepressant-like effects of Morinda officinalis oligosaccharides. The expression of brain-derived neurotrophic factor, phosphorylated-Ser9-glycogen synthase kinase 3β, β-catenin, and synaptic proteins was determined in the medial prefrontal cortex and the orbitofrontal cortex by western blot. Results: We found that Morinda officinalis oligosaccharides effectively ameliorated chronic unpredictable stress-induced depression-like behaviors in the sucrose preference test and forced swim test. The Morinda officinalis oligosaccharides also significantly rescued chronic unpredictable stress-induced abnormalities in the brain-derived neurotrophic factor-glycogen synthase kinase-3β-β-catenin pathway and synaptic protein deficits in the medial prefrontal cortex but not orbitofrontal cortex. The activation of glycogen synthase kinase-3β by the phosphoinositide-3 kinase inhibitor LY294002 abolished the antidepressant-like effects of Morinda officinalis oligosaccharides in the forced swim test. Naïve rats that were treated with Morinda officinalis oligosaccharides exhibited resilience to chronic unpredictable stress, accompanied by increases in the expression of brain-derived neurotrophic factor, phosphorylated-Ser9-glycogen synthase kinase-3β, and β-catenin in the medial prefrontal cortex. Conclusion: Our findings indicate that the brain-derived neurotrophic factor-glycogen synthase kinase-3β-β-catenin pathway in the medial prefrontal cortex may underlie the antidepressant-like effect of Morinda officinalis oligosaccharides and resilience to stress.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The molecular neurobiology of depression
Krishnan, V., & Nestler, E. J. (2008) · Nature · doi:10.1038/nature07455 · Cited by 2,889 · cited 2×
“, 2014), and the restoration of BDNF underlies the therapeutic efficacy of antidepressant treatment (Krishnan and Nestler, 2008; Autry et al., 2011; Monteggia et al., 2013; Duman and Aghajanian, 2014).”
BackgroundBelmaker, R. H., & Agam, G. (2008) · New England Journal of Medicine · doi:10.1056/nejmra073096 · Cited by 2,166
NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
Autry, A. E., Adachi, M., Nosyreva, E., Na, E. S., Los, M. F., Cheng, P.-F., Kavalali, E. T., & Monteggia, L. M. (2011) · Nature · doi:10.1038/nature10130 · Cited by 1,926 · cited 3×
“…in the pathophysiology of depression (Shimizu et al., 2003; Duman and Monteggia, 2006; Frodl et al., 2007; Groves, 2007; Licinio et al., 2009; Autry et al., 2011; Duman and Aghajanian, 2014; Hosang et al., 2014; Molendijk et al., 2014), and the restoration of BDNF underlies the…”
BackgroundSynaptic Dysfunction in Depression: Potential Therapeutic Targets
Duman, R. S., & Aghajanian, G. K. (2012) · Science · doi:10.1126/science.1222939 · Cited by 1,651 · cited 4×
“…synaptic plasticity, and neurogenesis (Li and Jope, 2010; Garza et al., 2012), which in turn exerts antidepressant effects (Beurel et al., 2011; Duman and Aghajanian, 2012; Zhu et al., 2013). β-Catenin has also been implicated in neuropsychiatric disorders, including depression (Madsen…”
BackgroundResultInfluentialDecreased serum brain-derived neurotrophic factor levels in major depressed patients
Karege, F., Perret, G., Bondolfi, G., Schwald, M., Bertschy, G., & Aubry, J.-M. (2002) · Psychiatry Research · doi:10.1016/s0165-1781(02)00005-7 · Cited by 1,232
Shimizu, E., Hashimoto, K., Okamura, N., Koike, K., Komatsu, N., Kumakiri, C., Nakazato, M., Watanabe, H., Shinoda, N., Okada, S.-I., et al. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00181-1 · Cited by 1,151 · cited 2×
“…(BDNF) plays a critical role in the pathophysiology and treatment of depression and is involved in the therapeutic response to antidepressants (Shimizu et al., 2003; Duman and Monteggia, 2006; Frodl et al., 2007; Groves, 2007; Licinio et al., 2009; Autry et al., 2011; Duman and Aghajanian,…”
BackgroundLi, N., Liu, R.-J., Dwyer, J. M., Banasr, M., Lee, B., Son, H., Li, X.-Y., Aghajanian, G., & Duman, R. S. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.12.015 · Cited by 1,082
Molendijk, M. L., Spinhoven, P., Polak, M., Bus, B. A. A., Penninx, B. W. J. H., & Elzinga, B. M. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.105 · Cited by 702 · cited 4×
“…and Monteggia, 2006; Frodl et al., 2007; Groves, 2007; Licinio et al., 2009; Autry et al., 2011; Duman and Aghajanian, 2014; Hosang et al., 2014; Molendijk et al., 2014), and the restoration of BDNF underlies the therapeutic efficacy of antidepressant treatment (Krishnan and Nestler,…”
BackgroundResultInfluentialA Memory Retrieval-Extinction Procedure to Prevent Drug Craving and Relapse
Xue, Y.-X., Luo, Y.-X., Wu, P., Shi, H.-S., Xue, L.-F., Chen, C., Zhu, W.-L., Ding, Z.-B., Bao, Y.-P., Shi, J., et al. (2012) · Science · doi:10.1126/science.1215070 · Cited by 511 · cited 1×
“The western-blot assays were based on previous studies (Lu et al., 2005; Wang et al., 2010; Xue et al., 2012).”
MethodFrodl, T., Schüle, C., Schmitt, G., Born, C., Baghai, T., Zill, P., Bottlender, R., Rupprecht, R., Bondy, B., Reiser, M., et al. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.4.410 · Cited by 394 · cited 1×
“The loss of BDNF is involved in the pathophysiology of depression (Shimizu et al., 2003; Duman and Monteggia, 2006; Frodl et al., 2007; Groves, 2007; Licinio et al., 2009; Autry et al., 2011; Duman and Aghajanian, 2014; Hosang et al., 2014; Molendijk et al., 2014), and the restoration of BDNF…”
Background
Cited by
Depression and Cognitive Impairment—Extrahepatic Manifestations of NAFLD and NASH
Colognesi, M., Gabbia, D., & De Martin, S. (2020) · Biomedicines · doi:10.3390/biomedicines8070229 · Cited by 98
“An impaired Wnt/β-catenin signaling pathway was reported to be involved in the pathogenesis of depression and AD [54,55]; thus, the dysregulated expression of proteins of this pathway observed in NAFLD rats could also be responsible for related cognitive impairment [56].”
BackgroundYu, Z., Chen, N., Hu, D., Chen, W., Yuan, Y., Meng, S., Zhang, W., Lu, L., Han, Y., & Shi, J. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00004 · Cited by 52
Self-citationJing, Q., Ren, L., Deng, X., Zhang, N., Fu, M., Wang, G., Jiang, X.-R., Lin, S.-R., & Ming, C.-R. (2020) · Journal of Acupuncture and Meridian Studies · doi:10.1016/j.jams.2020.03.065 · Cited by 17
Li, Y., Jiang, Y., Zhang, Z., Loake, V. I. P., Bao, X., & Loake, G. J. (2024) · Food Science & Nutrition · doi:10.1002/fsn3.4145 · Cited by 9
Metadata
- Authors
- Xu, L.-Z., Xu, D.-F., Han, Y., Liu, L.-J., Sun, C.-Y., Deng, J.-H., Zhang, R.-X., Yuan, M., Zhang, S.-Z., Li, Z.-M., Xu, Y., Li, J.-S., Xie, S.-H., Li, S.-X., Zhang, H.-Y., & Lu, L.
- Venue
- International Journal of Neuropsychopharmacology
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-10-11
- Volume
- 20
- Issue
- 1
- Pages
- pyw088
- ISSN
- 1461-1457 (ISSN-L)
- 1469-5111
- OpenAlex
- W2530950274
- Cited by
- 54
- References
- 20
- FWCI
- 3.63
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: BDNF-GSK-3β-β-Catenin Pathway in the mPFC Is Involved in Antidepressant-Like Effects of Morinda officinalis Oligosaccharides in Rats. https://app.cochat.ai/papers/10.1093/ijnp/pyw088
- The paper
- Xu, L.-Z., Xu, D.-F., Han, Y., Liu, L.-J., Sun, C.-Y., Deng, J.-H., Zhang, R.-X., Yuan, M., Zhang, S.-Z., Li, Z.-M., Xu, Y., Li, J.-S., Xie, S.-H., Li, S.-X., Zhang, H.-Y., & Lu, L. (2016). BDNF-GSK-3β-β-Catenin Pathway in the mPFC Is Involved in Antidepressant-Like Effects of Morinda officinalis Oligosaccharides in Rats. International Journal of Neuropsychopharmacology. https://doi.org/10.1093/ijnp/pyw088
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.